Advertisement · 728 × 90

Posts by The Lancet Microbe

Post image Post image Post image Post image

Highlights from late-breaking @TheLancet at #ESCMIDGlobal2026 📊

🔹 WGS + AI for RR-TB → better outcomes
🔹 UTI → nitrofurantoin best; fosfomycin worst
🔹 H5 immunity → partial cross-protection
🔹 M. pneumoniae CAP → steroids speed recovery

🚀 Precision + smarter antimicrobial use are shaping ID

1 day ago 22 9 4 3
Post image

Key take-home at #ESCMIDGlobal2026:

🧬 Partial cross-reactive immunity to H5 exists
💉 Likely from prior seasonal influenza exposure
⚠️ May not prevent infection—but could blunt severity

👉 Population not fully naïve to H5N1 👀

1 day ago 11 6 1 0
Post image

New data at #ESCMIDGlobal2026:

🧬 Functional N1 antibodies detected against both seasonal & avian influenza
🔗 Strong correlation between responses
💉 Likely driven by prior H1N1 exposure (infection or vaccination)

👉 Population may be less immunologically naïve than assumed

1 day ago 8 5 1 0
Post image

H5 spillover is increasing—but the key question is immunity.

🦠 Frequent spillover: poultry → mammals → humans (no sustained transmission)
⚠️ Pandemic risk hinges on spread in an immunologically naïve population

👉 Are we more vulnerable than we think? #ESCMIDGlobal2026

1 day ago 14 5 1 0
Post image Post image

H5 avian influenza at #ESCMIDGlobal2026:

🦠 Expanding host range → birds, mammals (incl. cattle), occasional human cases
🌍 Now across 6 continents with rising spillover
⚠️ Pandemic risk = spread in an immunologically naïve population

No sustained human transmission—yet 👀

1 day ago 12 6 1 0
Post image

Next Up! at #ESCMIDGlobal2026:

🦠 Population immunity to highly pathogenic avian influenza (H5) in healthcare workers

Early insights into immune responses—and what this means for exposure risk and pandemic preparedness 👀

#Lancet

1 day ago 8 4 1 0
Preview
Characterisation of immune responses targeting highly pathogenic avian influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis Together, our findings suggest that partial cross-reactive immunity to A(H5) influenza viruses exists in humans, likely induced by previous exposures to seasonal influenza viruses. This partial cross-...

Being presented tomorrow afternoon at #ESCMIDGlobal2026 as part of the Lancet session (Hall A3-1):

Characterisation of immune responses targeting highly pathogenic avian #influenza A(H5) viruses in health-care workers in the Netherlands

www.thelancet.com/journals/lan...

2 days ago 2 2 0 1
Preview
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study The findings of this large real-world study confirm that maribavir is an effective and well tolerated option for CMV infection and disease in HCT recipients.

New Research, oral presentation, Lancet Late Breaker session, #ESCMIDGlobal2026, 20 April

Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study

www.thelancet.com/journals/lan...

2 days ago 3 2 0 3
Promotional card. Contact Stephanie Becker regarding content enquiries at stephanie.becker@lancet.com. Copyright: Elsevier Ltd.

Promotional card. Contact Stephanie Becker regarding content enquiries at stephanie.becker@lancet.com. Copyright: Elsevier Ltd.

Stephanie Becker, Senior Editor, welcomes queries from #ESCMIDGlobal2026 attendees. Our journals are committed to supporting you on every stage of your publication journey. Learn more about our scope and global reach & impact here: hubs.li/Q03BLcyV0
@escmid.bsky.social

1 week ago 0 1 0 0
Advertisement
Post image

The May issue of @lancetgastrohep.bsky.social is out now at www.thelancet.com/gastrohep!

Content this month includes #colorectalsurgery, #colorectalcancer, #viralhepatitis + more

#GastroSky #MedSky #LiverSky #HepSky

1 week ago 2 2 0 0
Post image

New research article

Characterisation of immune responses targeting highly pathogenic avian #influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #OpenAccess #OA

1 week ago 2 4 0 0
Post image

The April 2026 issue of The Lancet Regional Health - Americas is now available online!

lnkd.in/gcRM-wYU
In this issue: #USDietaryGuidelines, #NosocomialInfections, #LongCOVID, #OropoucheVirus, #RenalCellCarcinoma, #ColorectalCancer, #LungCancer, #YellowFever, #OpioidUseDisorder, and much more.

1 week ago 1 1 0 0
Video

Enhance your clinical knowledge today through patient case studies, graphical summaries, & more.

🩺 Visit The Lancet’s Clinical Resources hub: spkl.io/63326A2CLp

1 week ago 7 2 0 0
Post image

New research article

Classification and sequencing of #hepatitis D virus from a large cohort of chronically infected individuals paired with co-infecting hepatitis B virus sequencing: a genomic characterisation study

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #ViroSky #HDV #HBV #OA

1 week ago 1 2 0 0
April cover of The Lancet Microbe

April cover of The Lancet Microbe

Our April issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #CRISPR #Bordetella #pertussis #microbiome #MicrobiotaTransplant #aspergillosis #BSI #AMR

#IDSky #ClinMicro #OA

1 week ago 4 3 0 2
Post image

What drives better outcomes?

Receiving ≥3 susceptible drugs was key to treatment success & very short regimens (≤9 months) were linked to worse outcomes.

Optimising regimen strength & tracking relapse-free survival should be central to MDR-TB care.

1 week ago 0 1 0 0
Post image

Multidrug-resistant #TB (MDR-TB) outcomes may be better than we think.

In a national cohort from Latvia, only 4.8% met WHO-defined cure—but 76.9% achieved long-term relapse-free survival.
👇
thelancet.com/journals/lan...

1 week ago 1 1 1 0
Post image Post image

📅 Ursula Hofer and Saleha Hassan will be attending ESCMID 2026, #ESCMIDGlobal2026, April 17-21, 2026 in Munich on behalf of The Lancet Infectious Diseases!

📧Feel free to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BL6Th0

1 week ago 1 1 1 1
Advertisement
Post image

📢 New Issue Alert. The latest eBioMedicine issue is out now—featuring cutting-edge #TranslationalResearch across #GlobalHealth, #AI, #neuroscience, #oncology & more. 🔬 From maternal–fetal health to AI in clinical research, explore new insights shaping the future of medicine.

1 week ago 0 1 0 0
Save the Date for the Lyon One Health Summit, 7 April 2026.

Save the Date for the Lyon One Health Summit, 7 April 2026.

🌐 One Health is on the agenda.

Join The Lancet’s Richard Horton live at the One Health Summit High-level Session.

Tomorrow, global leaders meet in Lyon & online to accelerate action—and The Lancet is part of it.

Learn more: spkl.io/63321A2ZrU

2 weeks ago 6 5 0 0
Promotional card announcing the launch of The Lancet Regional Health - Eastern Mediterranean. Text on card reads: Discover a new open access journal advancing clinical practice and health policy in the Eastern Mediterranean. Image depicts a woman sitting in a chair while speaking to a doctor holding an electronic tablet.

Promotional card announcing the launch of The Lancet Regional Health - Eastern Mediterranean. Text on card reads: Discover a new open access journal advancing clinical practice and health policy in the Eastern Mediterranean. Image depicts a woman sitting in a chair while speaking to a doctor holding an electronic tablet.

🆕 Introducing The Lancet Regional Health – Eastern Mediterranean, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in the Eastern Mediterranean.

Discover the new addition to The Lancet Group at: spkl.io/63328AFIyw #medsky

2 weeks ago 3 7 0 0
Research in context panel for paper published in The Lancet Neurology, entitled "Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023" Copyright: 2026 Elsevier Ltd. All rights reserved.

Research in context panel for paper published in The Lancet Neurology, entitled "Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023" Copyright: 2026 Elsevier Ltd. All rights reserved.

In 2023, there were over 250,000 deaths from meningitis globally, with over one third in children under five, suggests most comprehensive global assessment to date.

Find out more in @thelancetneuro.bsky.social: spkl.io/63327AF85U @ihmeuw.bsky.social

3 weeks ago 5 5 0 0
Figure: Organ dysfunctions in sepsis. Created in BioRender. Singer, M (2025) https://BioRender.com/l1o1l55. ARDS=acute respiratory distress syndrome. Copyright: Elsevier Ltd. All rights are reserved.

Figure: Organ dysfunctions in sepsis. Created in BioRender. Singer, M (2025) https://BioRender.com/l1o1l55. ARDS=acute respiratory distress syndrome. Copyright: Elsevier Ltd. All rights are reserved.

Sepsis is a serious condition where the body’s response to an infection becomes out of control and starts to damage its own organs.

A Seminar explores the complexity of the condition, and discusses current challenges and future developments in care: spkl.io/63323AFBJZ

3 weeks ago 21 11 1 1
Post image

New review article

WHO assessment of the preclinical #antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #MycoSky #OpenAccess #OA

3 weeks ago 2 3 0 2
Post image

New research article

Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #OpenAccess #OA

3 weeks ago 4 3 1 0
Preview
The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report Viral hepatitis represents a substantial burden of infectious disease globally, comparable with that caused by tuberculosis. Progress towards global hepatitis elimination is currently insufficient to ...

🆕 The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report

www.thelancet.com/journals/lan...

#LiverSky #IDSky #HepSky #MedSky

3 weeks ago 11 5 0 1
Preview
Treatment of multidrug-resistant Gram-negative infections: a stewardship imperative The rise of antimicrobial resistance poses a growing public health threat, driving increased patient morbidity and mortality, prolonged hospitalisations, and escalating health-care costs. In response,...

New comment

Treatment of multidrug-resistant Gram-negative infections: a stewardship imperative

www.thelancet.com/journals/lan...

3 weeks ago 0 1 0 2
Advertisement
Preview
Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort study Despite the availability of newer antibiotic agents, the estimated mortality and ongoing use of in-vitro discordant initial antibiotics remains unacceptably high among patients with DTR infections in ...

New Research

Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort study

www.thelancet.com/journals/lan...

3 weeks ago 1 4 1 4
Post image

Read our April issue!

Featuring the global burden of lower respiratory tract infections, comparing test algorithms for syphilis, and chikungunya vaccination in adolescents.

bit.ly/4m1TuYb

3 weeks ago 6 8 1 2
Post image

📢NEW: March issue now online featuring #obesity, #endometriosis, #KawasakiDisease, #diabetes, #SpinalCordInjury, #HIV, and much more with our editorial on risks of AI-generated health advice

…all available #free, #OpenAccess❗️

Read here: www.thelancet.com/issue/S2589-...

Attribution: Getty
#MedSky

3 weeks ago 3 5 0 1